Soligenix Announces Positive Phase 1B Clinical
Post# of 48
Soligenix Announces Positive Phase 1B Clinical Results with RiVaxTM, its Vaccine Against Ricin Toxin Exposure
Soligenix Announces Positive Phase 1B Clinical Results with RiVaxTM, its Vaccine Against Ricin Toxin Exposure